放射性标记FAPI PET/CT对头颈癌患者淋巴结分期的诊断效能:与18F-FDG PET/CT的比较
该研究通过检索PubMed、Cochrane和EMBASE数据库至2024年12月31日,汇总8项研究(14个结果)比较放射性标记FAPI与18F-FDG PET/CT检测头颈癌淋巴结转移的诊断效能。FAPI汇总灵敏度0.89、特异度0.93;18F-FDG汇总灵敏度0.91、特异度0.50。作者认为FAPI诊断效能良好,18F-FDG淋巴结分期特异度低,需未来大型多中心研究进一步全面评估FAPI的效用。
要点
- FAPI PET/CT汇总灵敏度0.89、特异度0.93,18F-FDG分别为0.91和0.50。
- 基于患者分析:FAPI灵敏度0.96、特异度0.96;18F-FDG为0.95和0.34。
- 基于病灶分析:FAPI灵敏度0.84、特异度0.94;18F-FDG为0.86和0.78。
核心结论
- 放射性标记FAPI对头颈癌患者转移性淋巴结检测显示良好的诊断效能。
- 18F-FDG PET/CT在头颈癌患者淋巴结分期中显示低特异度。
- 作者认为未来需大型多中心研究纳入更多患者,以更全面评估放射性标记FAPI用于头颈癌淋巴结分期的效用。
研究设计与样本
- 检索PubMed、Cochrane数据库和EMBASE数据库,从最早可检索日期至2024年12月31日,纳入比较放射性标记FAPI与18F-FDG PET/CT检测头颈癌患者转移性淋巴结诊断效能的研究。
- 共纳入8项研究(14个结果),合并估计各研究的灵敏度和特异度。
主要发现
- 汇总分析:FAPI PET/CT汇总灵敏度0.89、汇总特异度0.93;18F-FDG PET/CT汇总灵敏度0.91、汇总特异度0.50。
- 基于患者分析:FAPI估计灵敏度0.96、特异度0.96;18F-FDG估计灵敏度0.95、特异度0.34。
- 基于病灶分析:FAPI估计灵敏度0.84、特异度0.94;18F-FDG估计灵敏度0.86、特异度0.78。
- 基于颈侧分析:FAPI估计灵敏度0.88、特异度0.79;18F-FDG估计灵敏度0.91、特异度0.29。
关键数值与推荐
- 汇总分析(8项研究、14个结果):FAPI PET/CT灵敏度0.89、特异度0.93;18F-FDG PET/CT灵敏度0.91、特异度0.50。
- 基于患者分析:FAPI灵敏度0.96、特异度0.96;18F-FDG灵敏度0.95、特异度0.34。
- 基于病灶分析:FAPI灵敏度0.84、特异度0.94;18F-FDG灵敏度0.86、特异度0.78。
- 基于颈侧分析:FAPI灵敏度0.88、特异度0.79;18F-FDG灵敏度0.91、特异度0.29。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出未来需大型多中心研究纳入更多患者,以更全面评估放射性标记FAPI用于头颈癌淋巴结分期的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of the current study was to compare the diagnostic performances of radiolabeled FAPI and 18 F-FDG PET/CT for the detection of lymph node (LN) metastasis in head and neck cancer (HNC) patients. METHODS: The PubMed, Cochrane database, and EMBASE database, from the earliest available date of indexing through December 31, 2024, were searched for studies comparing diagnostic performances of radiolabeled FAPI and 18 F-FDG PET/CT for the detection of metastatic LN in HNC patients. We estimated pooled sensitivities and specificities across studies. RESULTS: Across 8 studies (14 results), the pooled sensitivity of FAPI PET/CT was 0.89 and the pooled specificity was 0.93. The pooled sensitivity of 18 F-FDG PET/CT was 0.91 and the pooled specificity was 0.50. On patient-based analysis, the estimated sensitivity and specificity of FAPI were 0.96 and 0.96, and those of 18 F-FDG were 0.95 and 0.34, respectively. On lesion-based analysis, the estimated sensitivity and specificity of FAPI were 0.84 and 0.94, and those of 18 F-FDG were 0.86 and 0.78, respectively. On neck side-based analysis, the estimated sensitivity and specificity of FAPI were 0.88 and 0.79, and those of 18 F-FDG were 0.91 and 0.29, respectively. CONCLUSIONS: Radiolabeled FAPI showed a good diagnostic performance for the detection of metastatic LN in HNC patients. Also, 18 F-FDG PET/CT revealed low specificity for LN staging in HNC patients. Future large multicenter research with more patients would be necessary to provide a more comprehensive overview of the usefulness of radiolabeled FAPI for LN staging in HNC patients.
引用
- Kim YS, Kim SJ. Diagnostic Performances of Radiolabeled FAPI PET/CT for Lymph Node Staging in Head and Neck Cancer Patients: Comparison With 18 F-FDG PET/CT. Clin Nucl Med. 2025. PMID: 40367495. doi:10.1097/RLU.0000000000005973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。